Moreover, in the field of nuclear medicine, Lassmann and colleagues have investigated the kinetics of γH2AX/53BP1 foci in peripheral leukocytes and lymphocytes in thyroid cancer patients being administered either 177Lu or 131I up to 144 hours post-infusion [12, 29, 30]. This evidence concerns the gene TP53BP1 and thyroid cancer.